Get the Stockscreener App
0.3174
2.62%
0.0081
Leap Therapeutics Inc stock is traded at $0.3174, with a volume of 471.11K.
It is up +2.62% in the last 24 hours and up +18.39% over the past month.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
See More
Previous Close:
$0.3093
Open:
$0.3126
24h Volume:
471.11K
Relative Volume:
0.26
Market Cap:
$13.15M
Revenue:
$1.50M
Net Income/Loss:
$-64.59M
P/E Ratio:
-0.1901
EPS:
-1.67
Net Cash Flow:
$-55.17M
1W Performance:
+12.39%
1M Performance:
+18.39%
6M Performance:
-20.67%
1Y Performance:
-89.46%
1-Day Range:
$0.2994
$0.318
1-Week Range:
$0.277
$0.318
52-Week Range:
$0.2223
$4.79
Leap Therapeutics Inc Stock (LPTX) Company Profile
Name
Leap Therapeutics Inc
Sector
Industry
Phone
617 252 4343
Address
47 THORNDIKE STREET, CAMBRIDGE, MA
Compare LPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.3174 | 12.82M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-29-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-28-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-04-21 | Initiated | Mizuho | Buy |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Jun-29-20 | Initiated | Piper Sandler | Overweight |
| Feb-11-20 | Initiated | Robert W. Baird | Outperform |
| Nov-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-13-19 | Resumed | Raymond James | Outperform |
| Mar-07-17 | Initiated | Ladenburg Thalmann | Buy |
View All
Leap Therapeutics Inc Stock (LPTX) Latest News
Is now a turning point for Leap Therapeutics Inc.2025 Price Momentum & Breakout Confirmation Alerts - newser.com
Reversal indicators forming on Leap Therapeutics Inc. stockPortfolio Growth Summary & Momentum Based Trading Signals - newser.com
Aug PostEarnings: Whats the beta of Leap Therapeutics Inc stock2025 Major Catalysts & High Accuracy Swing Entry Alerts - خودرو بانک
Buyout Rumor: What is Leap Therapeutics Incs 5 year growth outlookQuarterly Market Summary & Pattern Based Trade Signal System - خودرو بانک
Trend Recap: Is Leap Therapeutics Inc in accumulation or distribution phaseJuly 2025 Reactions & Verified Trade Idea Suggestions - خودرو بانک
FOMO Trade: Can Leap Therapeutics Inc. benefit from deglobalizationPortfolio Gains Summary & Daily Stock Momentum Reports - خودرو بانک
Leap Therapeutics Inc. stock trend outlook and recovery pathWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
Chart Watch: What is Leap Therapeutics Incs 5 year growth outlookDividend Hike & Entry Point Confirmation Alerts - خودرو بانک
Can Leap Therapeutics Inc. rally from current levels2025 Retail Activity & Low Drawdown Trading Techniques - newser.com
Geopolitics Watch: Can Leap Therapeutics Inc stock outperform in a bear marketJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - خودرو بانک
Options Flow: Is Leap Therapeutics Inc part of any ETFEntry Point & Fast Entry Momentum Alerts - خودرو بانک
Will Leap Therapeutics Inc. stock go up soonPortfolio Risk Summary & Comprehensive Market Scan Reports - newser.com
Order flow analysis tools used on Leap Therapeutics Inc.Recession Risk & Safe Entry Trade Signal Reports - newser.com
These biotechs are in the market for a buyer - The Business Journals
How to build a dashboard for Leap Therapeutics Inc. stock2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Using Python tools to backtest Leap Therapeutics Inc. strategiesJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Will Leap Therapeutics Inc. stock benefit from M&A2025 Market Overview & Verified Entry Point Detection - خودرو بانک
Backtesting results for Leap Therapeutics Inc. trading strategies2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Risk adjusted return profile for Leap Therapeutics Inc. analyzedQuarterly Performance Summary & Weekly High Return Stock Opportunities - newser.com
Intraday pattern recognizer results for Leap Therapeutics Inc.Jobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Can volume confirm reversal in Leap Therapeutics Inc.2025 Short Interest & Growth Focused Entry Point Reports - newser.com
Multi asset correlation models including Leap Therapeutics Inc.Weekly Volume Report & Technical Pattern Recognition Alerts - newser.com
Sentiment analysis tools applied to Leap Therapeutics Inc.2025 Earnings Impact & Weekly High Momentum Picks - newser.com
Leap Therapeutics Inc. stock volume spike explainedJuly 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Leap Therapeutics Granted Extension by Nasdaq - The Globe and Mail
Published on: 2025-09-12 14:15:00 - Newser
Regression analysis insights on Leap Therapeutics Inc. performance2025 Market Overview & Consistent Income Trade Ideas - Newser
Is Leap Therapeutics Inc. stock poised for growthQuarterly Growth Report & Weekly High Return Opportunities - Newser
Published on: 2025-09-12 06:13:05 - Newser
Risk vs reward if holding onto Leap Therapeutics Inc.Trade Exit Summary & Entry Point Confirmation Alerts - Newser
Using RSI to spot recovery in Leap Therapeutics Inc.Earnings Growth Report & Real-Time Chart Breakout Alerts - Newser
Signal strength of Leap Therapeutics Inc. stock in tech scannersMarket Activity Summary & Breakout Confirmation Trade Signals - Newser
is leap therapeutics inc. stock poised for growth2025 Earnings Impact & High Conviction Trade Alerts - Newser
Live market analysis of Leap Therapeutics Inc.M&A Rumor & Short-Term High Return Strategies - Newser
Leap Therapeutics Inc Stock (LPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):